Please login to the form below

Not currently logged in

The FDA vaccine advisory board recommends booster shots of both the J&J and Moderna vaccines

J&J cottonwood drive

J&J’s data showed that a second shot of its vaccine boosts protection to 94% against symptomatic moderate-to-severe infection when administered two months after the first dose

Biogen's ALS drug tofersen misses phase 3 endpoint

Biogen Idec buildingFollowing these results, Biogen will now expand its early access programme for tofersen to enable all eligible SOD1-ALS patients worldwide to receive the drug free of charge

AZ’s Imfinzi combination shows promise in liver cancer

AZ NEWCombining Imfinzi with experimental monoclonal antibody tremelimumab improved overall survival in patients with the most common form of liver cancer

New data shows Roche's Enspryng significantly reduces neuromyelitis optica spectrum disorder relapses

Enspryng is the first and only NMOSD treatment administered subcutaneously every four weeks

FDA approves Eli Lilly’s Verzenio in high risk early breast cancer

Eli Lilly new HQVerzenio is the first addition to adjuvant endocrine therapy approved by the FDA in nearly two decades for the treatment of HR+ HER2- early breast cancer

Bristol Myers Squibb announces data on Zeposia from DAYBREAK study in MS

BMS buildingThe data presented at ECTRIMS 2021 reinforces the efficacy and safety profile of Zeposia (ozanimod) in patients with relapsing forms of multiple sclerosis

Sanofi’s tolebrutinib demonstrates favourable one-year tolerability in patients with relapsing forms of multiple sclerosis

Sanofi receptionNew long-term data presented at ECTRIMS 2021 reinforces promising safety and efficacy profile

Data shows patients treated with Biogen's MS therapies mount an effective antibody response to COVID-19 vaccination

Biogen Idec buildingNew MS PATHS data was presented at ECTRIMS 2021

Results of AstraZeneca’s TACKLE phase 3 trial show antibody combination reduces risk of severe COVID-19 or death

AZ NEWThe antibody is the only long-acting combination shown to both prevent and treat COVID-19

clusterAdopting a creative IP approach towards biotech clusters

Why big pharma paradigm needs to change

COVID-19 Updates and Daily News

Featured jobs


Add my company
Visformatics (VISFO)

A team of strategic decision specialists with over 30+ years in the pharma space, we give you confidence through experience....

Latest intelligence

Breaking the silence: It’s time to talk about the menopause
Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
Senior Analytics Specialist joins Research Partnership...